{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:26Z","timestamp":1786120346586,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/mcg.0b013e3182431d56","type":"journal-article","created":{"date-parts":[[2012,1,31]],"date-time":"2012-01-31T05:46:33Z","timestamp":1327988793000},"page":"e38-e45","source":"Crossref","is-referenced-by-count":54,"title":["Long-Term Clinical Outcomes and Factors Predictive of Relapse After 5-Aminosalicylate or Sulfasalazine Therapy in Patients With Intestinal Behcet Disease"],"prefix":"10.1097","volume":"46","author":[{"given":"Yoon Suk","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Pil","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hee","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210305","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Behcets disease.","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"R2-2-20210305","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00002281-199401000-00007","article-title":"Behcets disease.","volume":"6","author":"ODuffy","year":"1994","journal-title":"Curr Opin Rheumatol"},{"key":"R3-2-20210305","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1038\/ajg.2009.331","article-title":"Development and validation of novel diagnostic criteria for intestinal Behcets disease in Korean patients with ileocolonic ulcers.","volume":"104","author":"Cheon","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R4-2-20210305","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00535-007-2090-4","article-title":"Development of consensus statements for the diagnosis and management of intestinal Behcets disease using a modified Delphi approach.","volume":"42","author":"Kobayashi","year":"2007","journal-title":"J Gastroenterol"},{"key":"R5-2-20210305","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10620-008-0337-4","article-title":"Gastrointestinal manifestations of Behcets disease.","volume":"54","author":"Ebert","year":"2009","journal-title":"Dig Dis Sci"},{"key":"R9-2-20210305","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1097\/MCG.0b013e3181c8a50f","article-title":"Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behcet disease.","volume":"44","author":"Chung","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R10-2-20210305","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/BF02235590","article-title":"Long-term clinical course and prognostic factors in intestinal Behcets disease.","volume":"43","author":"Choi","year":"2000","journal-title":"Dis Colon Rectum"},{"key":"R11-2-20210305","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00054725-200108000-00010","article-title":"Colonoscopic findings in intestinal Behcets disease.","volume":"7","author":"Lee","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"R12-2-20210305","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ibd.21313","article-title":"Development, validation, and responsiveness of a novel disease activity index for intestinal Behcets disease.","volume":"17","author":"Cheon","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R13-2-20210305","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0016-5085(92)90822-G","article-title":"Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohns disease. The Italian IBD Study Group.","volume":"103","author":"Prantera","year":"1992","journal-title":"Gastroenterology"},{"key":"R14-2-20210305","first-page":"200","article-title":"5-aminosalicylic acid in the prevention of relapses of Crohns disease in remission: a long-term study.","volume":"11","author":"Bresci","year":"1991","journal-title":"Int J Clin Pharmacol Res"},{"key":"R16-2-20210305","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0016-5085(97)70117-3","article-title":"A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohns disease. The Canadian Mesalamine for Remission of Crohns Disease Study Group.","volume":"112","author":"Sutherland","year":"1997","journal-title":"Gastroenterology"},{"key":"R17-2-20210305","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0016-5085(88)90677-4","article-title":"Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis.","volume":"94","author":"Riley","year":"1988","journal-title":"Gastroenterology"},{"key":"R19-2-20210305","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3109\/00365528708991929","article-title":"5-Aminosalicylic acid in the treatment of Crohns disease. A 16-week double-blind, placebo-controlled, multicentre study with Pentasa.","volume":"22","author":"Rasmussen","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"R20-2-20210305","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000200228","article-title":"Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohns disease.","volume":"45","author":"Mahida","year":"1990","journal-title":"Digestion"},{"key":"R22-2-20210305","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/ard.43.6.783","article-title":"Influence of age of onset and patients sex on the prevalence and severity of manifestations of Behcets syndrome.","volume":"43","author":"Yazici","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"R23-2-20210305","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2133.2007.08116.x","article-title":"Clinical features and natural course of Behcets disease in 661 cases: a multicentre study.","volume":"157","author":"Alpsoy","year":"2007","journal-title":"Br J Dermatol"},{"key":"R24-2-20210305","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","article-title":"The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center.","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"R25-2-20210305","first-page":"1008","article-title":"Effects of age and sex on Behcets disease.","volume":"26","author":"Bardak","year":"1999","journal-title":"J Rheumatol"},{"key":"R26-2-20210305","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/rheumatology\/35.2.139","article-title":"The ten-year mortality in Behcets syndrome.","volume":"35","author":"Yazici","year":"1996","journal-title":"Br J Rheumatol"},{"key":"R27-2-20210305","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/gast.1996.v111.pm8780560","article-title":"Crohns disease: influence of age at diagnosis on site and clinical type of disease.","volume":"111","author":"Polito","year":"1996","journal-title":"Gastroenterology"},{"key":"R28-2-20210305","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/gut.37.6.811","article-title":"Identifying patients with a high risk of relapse in quiescent Crohns disease. The GETAID Group. The Groupe dEtudes Therapeutiques des Affections Inflammatoires Digestives.","volume":"37","author":"Sahmoud","year":"1995","journal-title":"Gut"},{"key":"R29-2-20210305","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.ibd.0000225334.60990.5b","article-title":"A simple biological score for predicting low risk of short-term relapse in Crohns disease.","volume":"12","author":"Consigny","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"R30-2-20210305","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00004836-198808000-00011","article-title":"The clinical significance of serum C reactive protein levels in Crohns disease. Results of a prospective longitudinal study.","volume":"10","author":"Boirivant","year":"1988","journal-title":"J Clin Gastroenterol"},{"key":"R31-2-20210305","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/gut.2007.146357","article-title":"C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.","volume":"57","author":"Henriksen","year":"2008","journal-title":"Gut"},{"key":"R33-2-20210305","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/ibd.21517","article-title":"Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcets disease.","volume":"17","author":"Jung","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R34-2-20210305","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.MIB.0000173271.18319.53","article-title":"Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.","volume":"11","author":"Solem","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"R35-2-20210305","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ibd.20927","article-title":"Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohns disease.","volume":"15","author":"Schnitzler","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"R37-2-20210305","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1440-1746.2011.06688.x","article-title":"Clinical outcomes and factors for response prediction after the first course of corticosteroid therapy in patients with active ulcerative colitis.","volume":"26","author":"Yoon","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R38-2-20210305","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.3748\/wjg.v12.i16.2622","article-title":"Intestinal Behcets disease with esophageal ulcers and colonic longitudinal ulcers.","volume":"12","author":"Fujiwara","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R39-2-20210305","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00004836-200003000-00013","article-title":"The beneficial effect of mesalazine on esophageal ulcers in intestinal Behcets disease.","volume":"30","author":"Sonta","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"R40-2-20210305","first-page":"465","article-title":"Clinical features of intestinal Behcets disease and therapeutic effects of sulfasalazine.","volume":"29","author":"Yoo","year":"1997","journal-title":"Korean J Gastroenterol"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCG.0b013e3182431d56","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:35:08Z","timestamp":1786048508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004836-201205000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e3182431d56","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}